|
|
|
...read
the wave™
Nano
Research...Nano-Forschung
Nano Onderzoek
www.nano-Tsunami.com
|
International
nanobiotechnology project launch at the University
of Kent
|
An
international project in nanobiotechnology is being
launched at the University of Kent 30-31 January 2005.
The project’s primary objectives are the establishment
and maintenance of a European centre of excellence in
the area and it is funded for five-years in the first
instance.
Novel and Improved Nanomaterials, Chemistries and Apparatus
for Nano-Biotechnology (NACBO) is co-ordinated by the
University of Kent and is funded with a total of 15.6m
Euro, of which 8m Euro is granted from the European
Union, 0.5m from China and 7.1m from European industry.
Nanotechnology is still being explored by researchers
as a science and has been described as an ‘enabling
technology’ rather than a technology in its own right.
Ian Bruce, Professor of Nanobiotechnology at the University
of Kent, is one of many European researchers for whom
it is essential that Europe is recognised for its scientific
skills and excellence in this area as well as providing
competition and a direct challenge to the US, which
currently dominates the development of this emerging
science.
NACBO brings together key European industries and governmental
agencies with world class research institutes. Its objectives
are broad but focused and include the creation of novel
drug treatments using structured nanocomposite particles
coated or loaded with useful substances to improved
medical diagnostic systems, materials and methodologies
for use in forensic science, public health and welfare.
It also includes activities directly related to the
toxicological and safety issues surrounding nanomaterials
the results of which will be available to the world
through the project’s website.
Industries taking part are Philips (Aachen, Germany),
Degussa (Hamburg, Germany), Genetix (New Milton, UK)
and Savyon (Ashdod, Israel) together with the Health
Protection Agency (UK), Criminalpol (I) and the Istituto
Superiore per la Sanita (I). Kent is the only UK university
taking part in this project. The others are the University
of Urbino (I); East China University of Science and
Technology (Shanghai, PRC); Hebrew University at Jerusalem
(Israel) ; Shemaykin Ovchinikov Institute of Bioorganic
Chemistry (Moscow, Russia) and Bar Ilan University (Tel
Aviv, Israel).
According to Professor Bruce, such collaboration is
a principal strength of the project. ‘Collaboration
on this scale is relatively unknown in America, whereas
in Europe the benefits are widely acknowledged.’
For
further information, please contact:
Karen Baxter
Kent, University of
mediaoffice@kent.ac.uk
|
|
This
story has been adapted from a news release -
Diese Meldung basiert auf einer Pressemitteilung -
Deze
tekst is gebaseerd op een nieuwsbericht - |
|
|
|
|
who
is reading
the wave ?
|
missed
some news ?
click on archive photo
|
or
how about joining us
|
or
contacting us ?
|
about
us
|
our
mission
|
|
| |
| |
|
